These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24305452)

  • 1. Multidisciplinary approach to the management of myopathies.
    M King W; Kissel JT
    Continuum (Minneap Minn); 2013 Dec; 19(6 Muscle Disease):1650-73. PubMed ID: 24305452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REV-ERB and ROR: therapeutic targets for treating myopathies.
    Welch RD; Flaveny CA
    Phys Biol; 2017 Jun; 14(4):045002. PubMed ID: 28586319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of metabolic myopathies.
    Bhai SF; Vissing J
    Muscle Nerve; 2023 Sep; 68(3):250-256. PubMed ID: 37226557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaesthetic management of patients with myopathies.
    Schieren M; Defosse J; Böhmer A; Wappler F; Gerbershagen MU
    Eur J Anaesthesiol; 2017 Oct; 34(10):641-649. PubMed ID: 28719515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging treatments in myopathies.
    Antozzi C; Confalonieri P; Mantegazza R; Di Donato S
    Eur Neurol; 1997; 38(3):222-9. PubMed ID: 9363835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myopathies of endocrine origin: A review for physicians.
    Shah DN; Chorya HP; Ramesh NN; Gnanasekaram S; Patel N; Sethi Y; Kaka N
    Dis Mon; 2024 Jan; 70(1):101628. PubMed ID: 37718136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illness Weakness, Polyneuropathy and Myopathy: Diagnosis, treatment, and long-term outcomes.
    Latronico N; Rasulo FA; Eikermann M; Piva S
    Crit Care; 2023 Nov; 27(1):439. PubMed ID: 37957759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise training in metabolic myopathies.
    Vissing J
    Rev Neurol (Paris); 2016 Oct; 172(10):559-565. PubMed ID: 27663059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of Congenital Myopathies.
    Mah JK; Joseph JT
    Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1932-1953. PubMed ID: 27922501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel myosin-based therapies for congenital cardiac and skeletal myopathies.
    Ochala J; Sun YB
    J Med Genet; 2016 Oct; 53(10):651-4. PubMed ID: 27412953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular Therapies of Hereditary Myopathies in Adulthood - a Cursive Overview].
    Schoser B
    Fortschr Neurol Psychiatr; 2023 Apr; 91(4):164-168. PubMed ID: 36347473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle redox disturbances and oxidative stress as pathomechanisms and therapeutic targets in early-onset myopathies.
    Moulin M; Ferreiro A
    Semin Cell Dev Biol; 2017 Apr; 64():213-223. PubMed ID: 27531051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Myopathies.
    Tarnopolsky MA
    Continuum (Minneap Minn); 2022 Dec; 28(6):1752-1777. PubMed ID: 36537979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic myopathies.
    Pasnoor M; Barohn RJ; Dimachkie MM
    Curr Opin Neurol; 2018 Oct; 31(5):575-582. PubMed ID: 30080718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic myopathies: a practical approach.
    Lilleker JB; Keh YS; Roncaroli F; Sharma R; Roberts M
    Pract Neurol; 2018 Feb; 18(1):14-26. PubMed ID: 29223996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-related myopathies of which the clinician should be aware.
    Valiyil R; Christopher-Stine L
    Curr Rheumatol Rep; 2010 Jun; 12(3):213-20. PubMed ID: 20425521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on diagnostics of metabolic myopathies.
    Toscano A; Barca E; Musumeci O
    Curr Opin Neurol; 2017 Oct; 30(5):553-562. PubMed ID: 28763305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapies for RYR1-Related Myopathies: Where We Stand and the Perspectives.
    Beaufils M; Travard L; Rendu J; Marty I
    Curr Pharm Des; 2022; 28(1):15-25. PubMed ID: 34514983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creatine for treating muscle disorders.
    Kley RA; Tarnopolsky MA; Vorgerd M
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD004760. PubMed ID: 23740606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary myopathies and the heart.
    Finsterer J; Stöllberger C
    Scand Cardiovasc J; 2008 Feb; 42(1):9-24. PubMed ID: 18273731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.